- AU$4.27bn
- AU$5.17bn
- $1.62bn
- 90
- 67
- 68
- 85
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 14.39 | ||
PEG Ratio (f) | 1.81 | ||
EPS Growth (f) | 8.65% | ||
Dividend Yield (f) | 2.95% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.43 | ||
Price to Tang. Book | 10.21 | ||
Price to Free Cashflow | 12.42 | ||
Price to Sales | 1.47 | ||
EV to EBITDA | 12.85 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 6.64% | ||
Return on Equity | 6.45% | ||
Operating Margin | 10.08% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 1,613.7 | 2,026.9 | 1,952.1 | 1,655.1 | 1,619.3 | 2,044.54 | 2,157.57 | 1.56% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +6.65 | +71.77 | -34.55 | -13.72 | +1.93 | -0.84 | +11 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Ansell Limited is an Australia-based company offering safety solutions. The Company is an integrated manufacturer of personal protection equipment for healthcare and industrial workplaces. Its brands such as HyFlex, Ringers, MICROFLEX, TouchNTuff, GAMMEX, and AlphaTec. The Company is engaged in designing, developing, and manufacturing a range of hand, arm and body protection solutions and clothing. The Company operates through two segments: Healthcare Global Business Unit (GBU), and Industrial GBU. The Healthcare GBU segment is consists of surgical and examination gloves, healthcare safety devices and active infection prevention products for healthcare professionals and patients and single use industrial application gloves. The Industrial GBU segment comprises multi-use hand and body protection solutions for industrial worker environments and specialty applications. The Company operates other brands consists of the Kimtech, KleenGuard, The RightCycle Program, and APEX.
Directors
- John Bevan NEC (64)
- Neil Salmon CEO
- Zubair Javeed CFO
- Rikard Froberg CEX
- Darryl Nazareth CEX
- Amanda Manzoni CHO
- Francois Le Jeune SVP
- John Marsden SVP
- Deanna Johnston CIO
- Michael Gilleece GCN
- Augusto Accorsi OTH
- Paul Bryce OTH
- Renae Leary OTH
- Angie Phillips OTH
- Sean Sweeney OTH
- Martin Evans SEC
- Catherine Stribley SEC
- Leslie Desjardins NID (61)
- Morten Falkenberg NID (63)
- Nigel Garrard NID
- William Reilly NID
- Christina Stercken NID (62)
- Christine Yan NID (56)
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 16th, 1920
- Public Since
- January 2nd, 1981
- No. of Shareholders
- 38,270
- No. of Employees
- 15,951
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS
- Shares in Issue
- 145,407,248

- Address
- Level 3, 678 Victoria St, RICHMOND, 3121
- Web
- https://www.ansell.com/
- Phone
- +61 392707270
- Auditors
- KPMG
Latest News for ANN
Upcoming Events for ANN
Full Year 2025 Ansell Ltd Earnings Release
Similar to ANN
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
Atomo Diagnostics
Australian Stock Exchange - SEATS
FAQ
As of Today at 19:17 UTC, shares in Ansell are trading at AU$29.40. This share price information is delayed by 15 minutes.
Shares in Ansell last closed at AU$29.40 and the price had moved by +18.02% over the past 365 days. In terms of relative price strength the Ansell share price has outperformed the ASX All Ordinaries Index by +16.22% over the past year.
The overall consensus recommendation for Ansell is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Ansell dividend yield is 2.29% based on the trailing twelve month period.
Last year, Ansell paid a total dividend of $0.43, and it currently has a trailing dividend yield of 2.29%. We do not have any data on when Ansell is to next pay dividends.
We do not have data on when Ansell is to next pay dividends. The historic dividend yield on Ansell shares is currently 2.29%.
To buy shares in Ansell you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$29.40, shares in Ansell had a market capitalisation of AU$4.27bn.
Here are the trading details for Ansell:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: ANN
Based on an overall assessment of its quality, value and momentum Ansell is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Ansell is AU$34.41. That is 17.05% above the last closing price of AU$29.40.
Analysts covering Ansell currently have a consensus Earnings Per Share (EPS) forecast of $1.20 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ansell. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +0.23%.
As of the last closing price of AU$29.40, shares in Ansell were trading -7.41% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ansell PE ratio based on its reported earnings over the past 12 months is 14.39. The shares last closed at AU$29.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ansell's management team is headed by:
- John Bevan - NEC
- Neil Salmon - CEO
- Zubair Javeed - CFO
- Rikard Froberg - CEX
- Darryl Nazareth - CEX
- Amanda Manzoni - CHO
- Francois Le Jeune - SVP
- John Marsden - SVP
- Deanna Johnston - CIO
- Michael Gilleece - GCN
- Augusto Accorsi - OTH
- Paul Bryce - OTH
- Renae Leary - OTH
- Angie Phillips - OTH
- Sean Sweeney - OTH
- Martin Evans - SEC
- Catherine Stribley - SEC
- Leslie Desjardins - NID
- Morten Falkenberg - NID
- Nigel Garrard - NID
- William Reilly - NID
- Christina Stercken - NID
- Christine Yan - NID